0000947871-21-000575.txt : 20210518 0000947871-21-000575.hdr.sgml : 20210518 20210518080952 ACCESSION NUMBER: 0000947871-21-000575 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210517 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 21933932 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 ss278538_8k.htm CURRENT REPORT
0000064803 false 0000064803 2021-05-17 2021-05-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 18, 2021 (May 17, 2021)

CVS HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 001-01011 05-0494040
(State or other jurisdiction of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

     

 

One CVS Drive, Woonsocket, Rhode Island 02895
(Address of principal executive offices) (Zip Code)
   
Registrant’s telephone number, including area code: (401) 765-1500
   
Former name or former address, if changed since last report: N/A

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share CVS New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐
   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

   

 

 

 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Compensatory Arrangements of Certain Officers.

 

 

Appointment of Shawn M. Guertin as Executive Vice President and Chief Financial Officer

 

On May 17, 2021, the Board of Directors of CVS Health Corporation (“CVS Health”) appointed Shawn M. Guertin, age 57, to serve as Executive Vice President and Chief Financial Officer of CVS Health, effective May 28, 2021 (the “Start Date”). Mr. Guertin is currently a member of the board of directors of DaVita Inc. and TriNet Group, Inc. Mr. Guertin previously served as Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer of Aetna Inc. (“Aetna”) from January 2014 to May 2019 and as Senior Vice President, Chief Financial Officer and Chief Enterprise Risk Officer from February 2013 to January 2014. Prior to that role, he served as Head of Business Segment Finance at Aetna from April 2011 to February 2013 and held various leadership positions at Coventry Health Care, Inc., including Executive Vice President and Chief Financial Officer from January 2005 to December 2009, Senior Vice President and Chief Actuary from February 2003 to December 2005 and Vice President of Finance from April 1998 to February 2003. Mr. Guertin has also held various leadership positions at The Travelers and UnitedHealthcare.

 

In connection with Mr. Guertin’s appointment as Executive Vice President and Chief Financial Officer of CVS Health, Mr. Guertin will receive an annualized base salary of $1.25 million and will be eligible to participate in CVS Health’s annual bonus plan with a target annual cash bonus opportunity of 175% of his base salary, pro-rated for the 2021 performance year. In addition, Mr. Guertin’s target annual equity award compensation will be $7.0 million, which for calendar year 2021 will be comprised of 75% performance stock units and 25% stock options. Mr. Guertin will also receive a one-time cash sign-on bonus of $1.0 million (the “Sign-On Bonus Award”) and a one-time sign-on equity award with a grant date value of $3.0 million (the “Sign-On Equity Award”), which will vest on the third anniversary of the grant date, subject to the terms of the applicable award agreement. Mr. Guertin will be required to repay the Sign-On Bonus Award if CVS Health terminates his employment for cause or if Mr. Guertin voluntarily terminates his employment within two years of the Start Date. The Sign-On Equity Award will vest in full, with settlement on the original vesting date, in the event Mr. Guertin’s employment is terminated by CVS Health without cause. If Mr. Guertin voluntarily terminates his employment, or if his employment is terminated by CVS Health for cause, prior to the vesting date of the Sign-On Equity Award, the Sign-On Equity Award will be forfeited upon his termination of employment.

 

Mr. Guertin also entered into CVS Health’s customary change in control agreement for executives and a restrictive covenant agreement which includes, among other things, non-competition and non-solicitation covenants for the 18-month period following his employment with CVS Health.

 

There are no family relationships, as defined in Item 401 of Regulation S-K, between Mr. Guertin and any of CVS Health’s executive officers or directors or persons nominated or chosen to become a director or executive officer. Mr. Guertin has not engaged in any transaction with CVS Health during the last fiscal year, and he does not propose to engage in any transaction, that would be reportable under Item 404(a) of Regulation S-K.

 

Departure of Eva C. Boratto as Executive Vice President and Chief Financial Officer

 

On May 18, 2021, CVS Health also announced that Eva C. Boratto, currently the Executive Vice President and Chief Financial Officer of CVS Health, will be leaving CVS Health. Effective as of May 28, 2021, Ms. Boratto will cease to serve as Executive Vice President and Chief Financial Officer of CVS Health. Thereafter, Ms. Boratto will continue to be employed at CVS Health in a non-executive capacity to assist in the transition of her duties until her departure from CVS Health, which date has not yet been determined. In connection with Ms. Boratto’s departure, it is expected that she will enter into a separation agreement. Material terms of Ms. Boratto’s separation agreement have not been finalized.

 

   

 

 

 

Item 7.01 Regulation FD Disclosure.

 

A press release related to the matters described in Item 5.02 of this Current Report on Form 8-K is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 7.01 by reference.

 

The information in Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)        Exhibits.

 

The exhibits to this Current Report on Form 8-K are as follows:

 

INDEX TO EXHIBITS

 

Exhibit   Description
99.1   Press Release of CVS Health Corporation, dated May 18, 2021.
104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

     
    CVS HEALTH CORPORATION
     
Date: May 18, 2021 By: /s/ Colleen M. McIntosh
   

Colleen M. McIntosh

    Senior Vice President, Chief Governance Officer and Corporate Secretary
     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 EX-99.1 2 ss278538_ex9901.htm PRESS RELEASE

 

 

CVS Health Appoints Shawn Guertin Chief Financial Officer

 

Woonsocket, R.I., May 18, 2021 – CVS Health (NYSE: CVS) today announced it has appointed Shawn Guertin as Executive Vice President and Chief Financial Officer, effective May 28, 2021.

 

“Shawn is an extraordinary leader with a proven track record of developing financial strategies to help companies drive transformation,” said CVS Health President and CEO Karen S. Lynch. “His deep and broad health care experience will be invaluable and I’m confident he will play an integral role as we transform CVS Health to become an even bigger part of consumers’ everyday health.”

 

Guertin spent eight years at Aetna where he was Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer. He was the architect of the company’s finance strategy during a period of rapid growth and transformation. He helped Aetna enter new markets and grow through expansion and acquisitions and was key leader in shaping and affecting the merger with CVS Health in 2018. During his time in the role he was consistently recognized by Institutional Investor magazine as a top CFO.

 

Guertin succeeds Eva Boratto who is leaving the company after a successful 11-year career.

 

“Since I joined the company in 2010, CVS Health has undergone a period of significant growth and change,” said Boratto. “I am proud of our team and what we achieved. I am confident in CVS Health’s outlook for growth and long-term value going forward and am committed to helping the company through a seamless transition.”

 

Lynch added, “Eva served as CFO during a critical time following the Aetna acquisition and did an outstanding job supporting the integration of the two companies, managing our balance sheet, and helping us lead during the pandemic. Eva also drove our supplier diversity efforts, garnering external recognition of our leadership. We appreciate her achievements and dedication, and we wish Eva continued success.”

 

Guertin will report to Lynch and become a member of the company’s executive team. Guertin will be responsible for all aspects of the company’s financial strategy and operations, including accounting and financial reporting, investor relations, mergers and acquisitions, treasury and capital planning, investments, risk management, tax, budgeting and planning, and procurement.

 

“This is an exciting time for CVS Health,” said Guertin. “No other company has both the strong business and the customer reach and relationships to transform health care at scale. The pandemic has changed how Americans want to receive care and I’m excited to help CVS Health lead in a rapidly evolving marketplace.”

 

Most recently, Guertin served on the board of two public companies in health care and technology. He is an active supporter of Memorial Sloan Kettering and other charitable causes. Earlier in his career, Guertin was chief actuary and chief financial officer at Coventry Health Care, a leading health plan acquired by Aetna in 2012. He also served in a number of leadership positions at UnitedHealthcare and The Travelers.

 

   

 

 

 

 

CVS Health is reaffirming its 2021 guidance, which was previously provided on May 4, 2021. This includes its full year 2021 Adjusted EPS guidance range of $7.56 to $7.68 and full year 2021 cash flow from operations guidance range of $12.0 billion to $12.5 billion. CVS Health remains on track to achieve its low 3x leverage ratio goal in 2022.

 

As previously announced, CVS Health will hold its Investor Day on December 9, 2021.

 

###

 

About CVS Health

We are a diversified health services company with more than 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model makes us an integral part of people’s everyday health. From our innovative new services at HealthHUBTM locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we’re transforming health at www.cvshealth.com.

 

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. Statements in this press release that are forward-looking include, but are not limited to, those related to our financial performance for the full year 2021 and for future periods. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission (“SEC”) filings, including those set forth in the Risk Factors section and under the heading “Cautionary Statement Concerning Forward-Looking Statements” in our most recently filed Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021. You are cautioned not to place undue reliance on CVS Health’s forward-looking statements. CVS Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

 

This Press Release includes non-GAAP financial measures, including Adjusted EPS and leverage ratio. An explanation of these non-GAAP financial measures as well as reconciliations to the most directly comparable GAAP financial measures can be found on the Investor Relations portion of our website.

 

Media contact

T.J. Crawford

212-457-0583

CrawfordT2@CVSHealth.com

 

Investor contact

Katie Durant

401-770-6442

Katherine.Durant@CVSHealth.com

 

 

 GRAPHIC 3 image_001.jpg GRAPHIC begin 644 image_001.jpg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image_002.jpg GRAPHIC begin 644 image_002.jpg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end EX-101.SCH 5 cvs-20210517.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 cvs-20210517_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 cvs-20210517_pre.xml XBRL PRESENTATION FILE XML 8 ss278538_8k_htm.xml IDEA: XBRL DOCUMENT 0000064803 2021-05-17 2021-05-17 iso4217:USD shares iso4217:USD shares 0000064803 false 8-K 2021-05-17 CVS HEALTH CORPORATION DE 001-01011 05-0494040 One CVS Drive Woonsocket RI 02895 401 765-1500 false false false false Common Stock, par value $0.01 per share CVS NYSE false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover
May 17, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 17, 2021
Entity File Number 001-01011
Entity Registrant Name CVS HEALTH CORPORATION
Entity Central Index Key 0000064803
Entity Tax Identification Number 05-0494040
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One One CVS Drive
Entity Address, City or Town Woonsocket
Entity Address, State or Province RI
Entity Address, Postal Zip Code 02895
City Area Code 401
Local Phone Number 765-1500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol CVS
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://CVS/role/Cover Cover Cover 1 false false All Reports Book All Reports ss278538_8k.htm cvs-20210517.xsd cvs-20210517_lab.xml cvs-20210517_pre.xml ss278538_ex9901.htm image_001.jpg http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ss278538_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ss278538_8k.htm" ] }, "labelLink": { "local": [ "cvs-20210517_lab.xml" ] }, "presentationLink": { "local": [ "cvs-20210517_pre.xml" ] }, "schema": { "local": [ "cvs-20210517.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "CVS", "nsuri": "http://CVS/20210517", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ss278538_8k.htm", "contextRef": "From2021-05-17to2021-05-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://CVS/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "ss278538_8k.htm", "contextRef": "From2021-05-17to2021-05-17", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://CVS/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 16 0000947871-21-000575-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000947871-21-000575-xbrl.zip M4$L#!!0 ( #E!LE+5$&;^)@, ,T+ 0 8W9S+3(P,C$P-3$W+GAS M9+56V7+:,!1];F?Z#ZK?;=ED4@J!9!K2M$S(TI"%Y*4C;$'4R)(KR2Q_7\D; MFZ% 6IZDJW/.O=)=3.-D$E(PPD(2SIJ6Y[@6P,SG 6'#IG7?M;]T6^VV!4Z. M/[P'^M?X:-O@G& :U,$9]^TV&_ C<(5"7 ??,,,"*2Z.P .BL;'P M1A0KK ]23W5PZ%01L.TM9!\P"[BXOVT7LB]*174(Q^.QP_@(C;EXE8[/P^WT MN@JI6!9B[L3-?MO1+XGT"S)$A\^R.KDEO>$U^QRWGK^/Y2-ZO.CZ-VH<7=4> MGUXG<>A5^]T0P>G77Z=WD][IU&WS:J_RH_]TD;IL2/\%APCH5##9M.:N-SYP MN!C"BNMZL'?9Z28X*P76)Y2PUS*X5ZO58'*:0U>0D[Z@N?0!-,=])'&AK$_) M!CQA4B'F+^ #51#FP8

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end